Lyst Therapeutics' Seed VC Round

Lyst Therapeutics raised a round of funding on July 24, 2017. Investors include Rev1 Ventures.

Lyst Therapeutics is a project at Nationwide Children's Research Institute to determine the effect of LYST antibody on inhibiting the formation of tissue engineered vascular graft stenosis.…

Articles about Lyst Therapeutics' Seed VC Round: